首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2376篇
  免费   112篇
  国内免费   31篇
耳鼻咽喉   4篇
儿科学   95篇
妇产科学   21篇
基础医学   435篇
口腔科学   79篇
临床医学   287篇
内科学   540篇
皮肤病学   113篇
神经病学   46篇
特种医学   268篇
外科学   193篇
综合类   49篇
预防医学   83篇
眼科学   26篇
药学   165篇
中国医学   1篇
肿瘤学   114篇
  2018年   24篇
  2015年   30篇
  2014年   24篇
  2013年   88篇
  2012年   36篇
  2010年   44篇
  2009年   41篇
  2008年   32篇
  2007年   51篇
  2006年   56篇
  2005年   38篇
  2004年   28篇
  2003年   34篇
  2002年   28篇
  2001年   38篇
  2000年   34篇
  1999年   40篇
  1998年   85篇
  1997年   96篇
  1996年   107篇
  1995年   73篇
  1994年   75篇
  1993年   76篇
  1992年   43篇
  1991年   39篇
  1990年   45篇
  1989年   69篇
  1988年   59篇
  1987年   48篇
  1986年   54篇
  1985年   39篇
  1984年   56篇
  1983年   29篇
  1982年   31篇
  1981年   39篇
  1980年   49篇
  1979年   23篇
  1978年   27篇
  1977年   36篇
  1976年   40篇
  1975年   37篇
  1972年   24篇
  1971年   22篇
  1970年   28篇
  1965年   50篇
  1964年   50篇
  1963年   47篇
  1962年   41篇
  1961年   41篇
  1960年   65篇
排序方式: 共有2519条查询结果,搜索用时 15 毫秒
51.
The University of Oklahoma Medical Center has a comprehensive program of pediatric training, research and patient care. Establishment of the Oklahoma Health Center and its Children's Medical Center on the University campus will provide expanded opportunities for training and research in cooperation with other organizations concerned with child health and development.  相似文献   
52.
Thrombocytopoietic properties of oncostatin M   总被引:1,自引:2,他引:1  
Oncostatin M (OM) is a 28-kD glycoprotein that exhibits a panoply of biologic effects. Based on histologic observations of increased splenic megakaryocytes in nude mice implanted with an OM-secreting cell line, the thrombocytopoietic properties of OM in mice were investigated in culture and in vivo. Alone, OM did not induce megakaryocytic colony formation, but in combination with murine interleukin-3 (IL-3), OM markedly enhanced colony formation. The effects of OM on colony formation were similar to those of IL-6. OM alone augmented acetylcholinesterase in short-term marrow cultures. In normal mice, the administration of OM augmented platelet counts without increasing other circulating blood cell counts. The increment in counts exceeded that observed with IL-6. The kinetics of the OM response suggested that maximal increases in platelets occurred 3 days after the cessation of OM administration, irrespective of the duration of administration. In irradiated mice, OM administration accelerated platelet recovery and prevented the decrease in red blood cells observed in irradiated control animals. The data show that OM behaves as a megakaryocytic maturation factor in vitro and augments platelet production in vivo. Based on these animal data, OM may have potential clinical utility as a thrombocytopoietic agent.  相似文献   
53.
54.
55.
56.
57.
58.
MOHLER  DANIEL N.; CROCKETT  CHARLES L.  JR. 《Blood》1964,23(4):427-444
1. Three cases of hereditary hemolytic disease secondary to G-6-PD deficiency are described. Two of the cases were first cousins of Scotch-Irish-English descent and the mode of inheritance was believed to be sex-linked.The third case was of Turkish origin; no family studies were availale.

2. The mothers, who were heterozygous for G-6-PD deficiency, showed onlyminimal expression of the defect, which was manifested by a slightly decreasedred cell survival in both mothers and an abnormal methemoglobin reductiontest in one of them.

3. All three cases showed a more pronounced fall in erythrocyte ATP afterincubation with phenylhydrazine than that observed in primaquine-sensitiveNegroes whose red cells were less deficient in G-6-PD.

4. It is suggested that the inability of the G-6-PD-deficient erythrocyte tomaintain adequate levels of ATP may be an important factor in the pathogenesis of the hemolytic process.

Submitted on August 26, 1963 Accepted on October 24, 1963  相似文献   
59.
Several Australian obesity management guidelines have been developed for general practice but, to date, implementation of these guidelines has been shown to be inadequate. In this review, we explore the barriers to obesity treatment and propose a four-stage plan to manage individuals with obesity in general practice using a framework of a multidisciplinary team.Funding: Novo Nordisk.  相似文献   
60.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号